David Nunez

Texas . Austin - United States

David Nunez 的邮箱和电话

电子邮件 dav***@***.com

David Nunez 当前工作场所

Mesoblast Limited

Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Company's Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: • RYONCIL™ (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD) • Remestemcel-L for moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection • REVASCOR® for advanced chronic heart failure, and • MPC-06-ID for chronic low back pain due to degenerative disc disease. The US FDA has accepted for priority review Mesoblast's BLA to seek approval of RYONCIL to treat acute GVHD in children and set a PDUFA action date of September 30, 2020. The Company's proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide. Mesoblast's approach to product development is to ensure rigorous scientific investigations are performed with well-characterized cell populations in order to understand mechanisms of action for each potential indication. Extensive preclinical translational studies guide clinical trials that are structured to meet stringent safety and efficacy criteria set by international regulatory agencies. All trials are conducted under the continuing reviewof independent Data Safety Monitoring Boards comprised of independent medical experts and statisticians. Mesoblast has an extensive patent portfolio comprising approximately 1,000 patents and patent applications with protection extending through 2040 in all major markets. This intellectual property portfolio covers composition of matter, manufacturing, and therapeutic applications of mesenchymal lineage cells. The Company believes this patent estate provides strong global protection.

David Nunez 简介

公司 Mesoblast Limited
职位 Director Clinical Development
地点 United States
LinkedIn http://www.linkedin.com/in/david-j-n%c3%ba%c3%b1ez-27ab415
部门
头衔 Director Clinical Development

David Nunez 的常见问题(FAQs)

David Nunez 在哪家公司工作?

David Nunez 在 Mesoblast Limited 担任 Director Clinical Development

David Nunez 在 Mesoblast Limited 的职位是什么?

David Nunez 在 Mesoblast Limited 的职位是 Director Clinical Development

David Nunez 的电子邮件地址是什么?

David Nunez 的电子邮件地址是 dav***@***.com

David Nunez 的电话号码是什么?

David Nunez 的电话号码是 -

David Nunez 的工作电话号码是什么?

David Nunez 的公司电话号码是 +613****

David Nunez 从事哪个行业?

David Nunez 在 research 工作。

David Nunez 的同事是谁?

David Nunez 的一些同事包括David Nunez、Maria Cabreira、Suman Abraham、Jenny ZafirisAndrew Chaponnel、。

我如何联系 David Nunez?

David Nunez联系方式: 电子邮件地址:dav***@***.com 电话号码:-

David Nunez 的个人领英是多少

David Nunez 的个人领英是:http://www.linkedin.com/in/david-j-n%c3%ba%c3%b1ez-27ab415

David Nunez 的办公地点在哪里?

David Nunez 的办公地点:55 Collins Street, Level 38, Melbourne, Victoria, AU, 3000

同名人员

David Nunez

Consejero en Consejo Directivo de Anunciantes

David Nunez

Consultor de tecnologia

David Nunez

Software Developer at Payments Team

David Nunez

CEO y Director técnico

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展销采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google